Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Kripthonite Therapeutics ApS
APS
Active
CVR 43770209
Palle Juul-Jensens Boulevard 82, 8200
Aarhus N
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2023 · 3 years old
4 employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
Kripthonite Therapeutics ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
JS
Jan Stenvang
Management
Management
2026
Board of directors
Non-executive oversight
Name
Role
Member since
Current (5)
SB
Søren Bregenholt Frederiksen
Chairman
Chairman
2025
KM
Kristian Mark Jacobsen
Board of Directors
Board of Directors
2023
PH
Per Hjerrild
Board of Directors
Board of Directors
2023
TB
Thomas Bjørnskov Poulsen
Board of Directors
Board of Directors
2023
EV
Erik Vinther
Board of Directors
Board of Directors
2026
Former (1)
PH
Peter Horn Møller
Chairman
Chairman
2023 – 2025
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Thomas B. Poulsen Holding ApS
Company
20–24.99%
20–24.99%
2025
Hjerrild Chemistry Consulting ApS
Company
20–24.99%
20–24.99%
2025
Jacobsen Biotech ApS
Company
20–24.99%
20–24.99%
2025
Marigold Innovation ApS
Company
20–24.99%
20–24.99%
2025
Marigold Maturation Fund K/S
Company
15–19.99%
15–19.99%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Kripthonite Therapeutics ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
